TABLE 1.
PLA30 min | PBMT30 min | PLA6 h | PBMT6 h | ANOVA | ||||
Main Effect: Time | Main Effect: Condition | Interaction: Time × condition | ||||||
Nitrite (nmol/mg of protein) | Before | 0.38 ± 0.23 (0.23 to 0.53) |
0.39 ± 0.31 (0.19 to 0.59) |
0.33 ± 0.25 (0.17 to 0.49) |
0.30 ± 0.18 (0.18 to 0.41) |
p = 0.90 < 0.01 |
p = 0.55 = 0.04 |
p = 0.48 = 0.07 |
After | 0.34 ± 0.18 (0.22 to 0.46) |
0.37 ± 0.33 (0.16 to 0.59) |
0.33 ± 0.21 (0.20 to 0.47) |
0.34 ± 0.20 (0.22 to 0.47) |
||||
Δ% | 7.48 ± 58.75 (−29.84 to 44.81) |
−7.64 ± 20.63 (−20.76 to 5.46) |
28.25 ± 110.20 (−41.76 to 98.27) |
32.54 ± 89.21 (−24.14 to 89.22) |
p = 0.57 = 0.06 |
|||
Doppler ultrasonography | ||||||||
Peak Systolic Velocity F.a (cm/s) | Before | 65.05 ± 9.67 (59.20 to 70.90) |
61.20 ± 11.31 (54.36 to 68.03) |
74.86 ± 15.63 (65.41 to 84.31) |
68.40 ± 18.85 (57.01 to 79.80) |
p = 0.32 = 0.08 |
p = 0.02* = 0.25 (post hoc P ≥ 0.08) |
p = 0.97 < 0.01 |
After | 60.33 ± 13.37 (52.25 to 68.42) |
58.90 ± 17.81 (48.14 to 69.67) |
70.89 ± 21.73 (57.75 to 84.02) |
65.82 ± 18.06 (54.90 to 76.74) |
||||
Δ% | −7.20 ± 15.83 (−16.76 to 2.36) |
−1.35 ± 32.18 (−20.80 to 18.09) |
−2.50 ± 33.76 (−22.90 to 17.90) |
−2.78 ± 41.36 (−22.21 to 27.78) |
p = 0.82 = 0.09 |
|||
Pulsatility Index F.a (a.u.) | Before | 11.08 ± 5.84 (7.55 to 14.61) |
10.17 ± 4.83 (7.25 to 13.09) |
9.53 ± 4.89 (6.57 to 12.49) |
9.99 ± 3.23 (8.03 to 11.94) |
p = 0.21 = 0.12 |
p = 0.85 = 0.02 |
p = 0.83 = 0.01 |
After | 12.10 ± 4.98 (9.08 to 15.11) |
11.64 ± 5.31 (8.42 to 14.85) |
11.03 ± 7.20 (6.67 to 15.38) |
12.27 ± 7.69 (7.62 to 16.90) |
||||
Δ% | 19.47 ± 43.02 (−6.52 to 45.46) |
27.73 ± 72.87 (−16.66 to 71.41) |
17.44 ± 50.37 (−13.00 to 47.88) |
36.26 ± 84.07 (−14.54 to 87.07) |
p = 0.82 = 0.02 |
Values are expressed as mean ± SD (CI95%).
* = main condition effect; , partial eta squared; F.a., femoral artery; PBMT30 min, photobiomodulation treatment 30 min before exercise; PLA30 min = placebo treatment 30 min before exercise; PBMT6 h = photobiomodulation treatment 6 h before exercise; PLA6 h = placebo treatment 6 h before exercise n = 13.